As they readied to leave work Monday, some workers at the Food and Drug Administration were told to pack their laptops and ...

The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug ...

Communication between health-care professionals and individuals with cancer regarding the effects of treatment on sexual ...

Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his ...

The FDA has long believed it has the power to regulate lab-developed tests, but it only put out the rules under former President Biden.

The forced removal was Makary’s first major act as commissioner and sent a powerful signal to a stunned Washington that was ...

Moderna (MRNA) is another interesting choice today. MRNA stock has dropped 11.66% alongside the FDA news, the largest of the ...

The Senate has confirmed Dr Jay Bhattacharya as the new director of the NIH and Dr Marty Makary as the new commissioner of the FDA.

Peter Marks’ ouster comes at a time when the sector is already suffering through a years-long public markets slump.

The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug ...

(Reuters) -Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine ...